Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer.
about
Preoperative chemotherapy for resectable thoracic esophageal cancerPerioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagusNeoadjuvant therapy for gastroesophageal adenocarcinomaPredicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature ReviewPreoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant dataSystematic review: potential preventive effects of statins against oesophageal adenocarcinomaThe AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma.Preoperative therapy in locally advanced esophageal cancerTranslational research in thoracic surgery-the National Taiwan University Hospital experienceReevaluation of Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials Over the Past 20 YearsLocally advanced gastroesophageal junction tumor: a treatment dilemmaEsophageal squamous cell carcinoma - precursor lesions and early diagnosisCurrent Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan.Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junctionExocrine pancreatic insufficiency following esophagectomy.Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study.Recent advances in preoperative management of esophageal adenocarcinomaThe prognostic effect of perineural invasion in esophageal squamous cell carcinomaMagnetic Resonance Imaging (MRI) of Intratumoral Voxel Heterogeneity as a Potential Response Biomarker: Assessment in a HER2+ Esophageal Adenocarcinoma Xenograft Following Trastuzumab and/or Cisplatin Therapy.Adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers.ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS).Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy.Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial.Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancerTransthoracic vs transhiatal surgery for cancer of the esophagogastric junction: a meta-analysisSCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagusCommon variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection.The survival impact of XPA and XPC genetic polymorphisms on patients with esophageal squamous cell carcinoma.ZNF695 methylation predicts a response of esophageal squamous cell carcinoma to definitive chemoradiotherapy.Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma.Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.Perioperative therapy for esophageal cancer.The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction.Adjuvant chemotherapy versus surgery alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studies.Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience.Multimodality management of esophageal cancer.
P2860
Q24187910-7B4A3278-44B8-4324-9040-E35AEE53275EQ24202957-59D8934B-3A3C-4721-9A16-E04BD0B81FE2Q26746147-15220EEF-0F97-429E-B8C5-429EB74726DAQ26777898-37E7325D-F012-4510-BB7F-B9C8AC551E2FQ27010262-01766050-DE47-4EBA-839B-44A13CB68D65Q27024919-26ECC94C-A601-4662-9940-2F217D6612BEQ27853383-851A6766-C839-4A40-9F87-CCBC8E4687C8Q28070310-2C549CCB-AEB3-48CA-93C8-F4D339806843Q28073690-DDD32774-2A8C-4495-8AA2-0338F17B11ADQ28081365-CF4188A9-2669-418D-AE99-6B2321AE3466Q28082596-0FD38CBF-C9DA-4A8E-88C8-8D95710A79BEQ28395809-F7373FB8-82AE-443A-94EB-02CDADA54919Q30244382-4D04CAAD-721D-4027-9AEA-49911A165ADCQ30537735-3494A8D3-CCDE-447B-B725-320A024DD6EDQ33456528-F62B5C2E-720C-41FB-AB4E-2D83AF1B3DCBQ33564813-9C2A9FC8-7564-412D-9F83-D6AE53225049Q33589301-C4F42090-EB4C-4794-8608-BACCA227924BQ33593057-510DD6B5-53FD-49F5-9ED4-F960C840EF9FQ33611886-84D92FAF-1438-48E1-AC3E-94C4CA744A98Q33649971-5CCB96A5-3CB7-451C-9F81-B62236D42503Q33723639-D7D8F492-EF84-4063-892E-2F7D34E1BA9DQ33759688-221B5D9C-E544-4780-B918-443844FB6BDFQ33903723-7D2221D3-1A90-4E40-A5E7-2A14430CBE4FQ33906085-DB06035D-DA27-41BA-8A93-4CC30C6BFA61Q33918140-9A16F6ED-86C9-4906-AAB4-A8BCD943E6E3Q34008730-B52E342E-36D0-4A06-8E51-7433A1E74A9BQ34061012-21CE6B4C-7AC5-41FD-A47C-242A4F1245E3Q34298428-0D7D8CF4-5824-4C71-A87B-3DFF0441E827Q34374254-276F68E7-216A-499C-8BDB-0A4EF50D2C80Q34401264-A7DE194E-4044-4F9A-9D02-EE6CA3BFC2BEQ34441327-F3128F79-DF72-41F2-AB34-42294B0D6A29Q34469077-4E0636D4-F971-4E24-8550-1ED1E611E841Q34479911-0A7F67EA-0BD9-47CB-96D8-BBD72F58E55DQ34483744-5A6162A3-853D-48E9-AF19-3AE5835B5E9EQ34488692-5BDA3B24-8F35-4F33-8B2C-3C3F34E807FAQ34663544-F3C6AF8D-2E3F-460C-8467-D1EF681D9541Q34678579-BEC3AD08-7823-422A-AD9A-DAD09EAC7226Q34689864-9FAD57E4-6275-4D11-BA30-EE10A9FAADC9Q34824033-B97EC390-6EBA-4FA2-8E1B-7E37DFE4F565Q34981111-5C0F5851-115D-42AC-A000-4862B0586B83
P2860
Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Long-term results of a randomi ...... otherapy in esophageal cancer.
@en
Long-term results of a randomi ...... otherapy in esophageal cancer.
@nl
type
label
Long-term results of a randomi ...... otherapy in esophageal cancer.
@en
Long-term results of a randomi ...... otherapy in esophageal cancer.
@nl
prefLabel
Long-term results of a randomi ...... otherapy in esophageal cancer.
@en
Long-term results of a randomi ...... otherapy in esophageal cancer.
@nl
P2093
P356
P1476
Long-term results of a randomi ...... otherapy in esophageal cancer.
@en
P2093
John Bancewicz
Peter I Clark
Ruth E Langley
Sally P Stenning
William H Allum
P304
P356
10.1200/JCO.2009.22.2083
P407
P577
2009-09-21T00:00:00Z